Page last updated: 2024-11-03

opc 12759 and Intestinal Diseases

opc 12759 has been researched along with Intestinal Diseases in 9 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.

Research Excerpts

ExcerptRelevanceReference
"Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly-used medications, and ailments such as arthritis or heart disease, require long-term use of these drugs, which can induce gastroenteropathy with bleeding and ulcers."3.11The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study. ( Choi, YJ; Ha, YJ; Kang, EH; Kim, HS; Kim, KJ; Kim, N; Lee, DH; Lee, YJ; Liu, F; Oh, DJ; Park, YS; Shin, CM; Yoon, H, 2022)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Oh, DJ1
Yoon, H1
Kim, HS1
Choi, YJ1
Shin, CM1
Park, YS1
Kim, N2
Lee, DH1
Ha, YJ1
Kang, EH1
Lee, YJ1
Kim, KJ1
Liu, F1
Xu, N1
Zhang, C1
Jing, L1
Mou, S1
Cao, X1
Yu, Z1
Kurokawa, S1
Katsuki, S1
Fujita, T1
Saitoh, Y1
Ohta, H1
Nishikawa, K1
Sato, Y2
Ohira, K1
Yamada, M1
Kato, M1
Satoh, H1
Amagase, K1
Takeuchi, K2
Watanabe, T2
Takeuchi, T1
Handa, O1
Sakata, Y1
Tanigawa, T2
Shiba, M2
Naito, Y1
Higuchi, K1
Fujimoto, K1
Yoshikawa, T1
Arakawa, T2
Otani, K1
Shimada, S1
Nadatani, Y1
Nagami, Y1
Tanaka, F1
Kamata, N1
Yamagami, H1
Tominaga, K1
Fujiwara, Y1
Mizukami, K1
Murakami, K1
Abe, T1
Inoue, K1
Uchida, M1
Okimoto, T1
Kodama, M1
Fujioka, T1
Niwa, Y1
Nakamura, M1
Ohmiya, N1
Maeda, O1
Ando, T1
Itoh, A1
Hirooka, Y1
Goto, H1
Mizoguchi, H1
Ogawa, Y1
Kanatsu, K1
Tanaka, A1
Kato, S1

Reviews

1 review available for opc 12759 and Intestinal Diseases

ArticleYear
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Digestion, 2017, Volume: 95, Issue:1

    Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Gastrointestinal Microbiome; Hu

2017

Trials

5 trials available for opc 12759 and Intestinal Diseases

ArticleYear
The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study.
    The Korean journal of internal medicine, 2022, Volume: 37, Issue:6

    Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Intestinal Diseases; Pilot Projects; Ulcer

2022
A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
    Journal of gastroenterology, 2014, Volume: 49, Issue:2

    Topics: Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule Endoscop

2014
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Aged; Alanine; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Dose-Response Relationship, Drug; Doub

2015
Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
    World journal of gastroenterology, 2011, Dec-14, Volume: 17, Issue:46

    Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule E

2011
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Journal of gastroenterology, 2008, Volume: 43, Issue:4

    Topics: Adult; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Capsule Endoscopy; Cross

2008

Other Studies

3 other studies available for opc 12759 and Intestinal Diseases

ArticleYear
Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
    International immunopharmacology, 2021, Volume: 90

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Claudin-1; Cytokines; Diclofenac; Disease

2021
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 348, Issue:2

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Respo

2014
Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:10

    Topics: Alanine; Ampicillin; Animals; Anti-Ulcer Agents; Bacterial Translocation; Catalase; Dose-Response Re

2001